TABLE 1

Summary of pEC50, emax, and R2 values from BRET experiments

CXCR5 Variantβ-arrestin IsoformCell TypepEC50 ± 95% CIRelative Emax to WT ± 95% CIR2
Wild-typeβ-arrestin1HEK2937.05 ± 0.240.95 ± 0.080.94
Wild-typeβ-arrestin2HEK2937.24 ± 0.330.94 ± 0.080.88
Wild-typeβ-arrestin1DKO6.61 ± 0.180.98 ± 0.120.97
Wild-typeβ-arrestin2DKO6.65 ± 0.311.00 ± 0.570.90
Distalβ-arrestin1DKO7.31 ± 0.730.05 ± 0.050.55
Distalβ-arrestin2DKO7.31 ± NA0.09 ± 0.340.01
Medialβ-arrestin1DKO6.23 ± 0.220.51 ± 0.170.95
Medialβ-arrestin2DKO6.30 ± 0.270.70 ± 0.390.91
Proximalβ-arrestin1DKO6.20 ± 0.250.99 ± 0.100.94
Proximalβ-arrestin2DKO6.27 ± 0.360.97 ± 0.450.87
  • pEC50 ± 95% confidence interval (CI), relative Emax ± 95% CI, and R2 values of CXCR5 wild-type and phospho-site variants β-arrestin1 and β-arrestin2 recruitment in both wild-type HEK293 cells and β-arrestin1/2 double knock (DKO) HEK293 cells.